STTK CIK: 1680367

Shattuck Labs, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
288
FY22:
185
FY23:
143
FY24:
79.2
FY25:
82.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
10.3
FY22:
20.7
FY23:
16.3
FY24:
11.8
FY25:
8.55
Total assets
Change from FY21 to FY25
millions USD
FY21:
299
FY22:
205
FY23:
160
FY24:
91.0
FY25:
91.0

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
24.6
FY22:
25.0
FY23:
11.5
FY24:
8.92
FY25:
7.05
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.21
FY22:
4.20
FY23:
3.41
FY24:
2.51
FY25:
1.58
(positive)
Change from FY21 to FY25
millions USD
FY21:
272
FY22:
176
FY23:
145
FY24:
79.6
FY25:
82.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
299
FY22:
205
FY23:
160
FY24:
91.0
FY25:
91.0

All amounts in millions USD Data source:SEC EDGAR